Absence of a Relationship between Antibodies to Hepatitis C Virus and Hepatocellular Carcinoma in Mozambique

Marie-Christine DazzaINSERM U13/IMEA, Hopital Claude Bernard, Servicio de Gatroenterologia, Hospital Central de Maputo, Innogenetics, Paris, France

Search for other papers by Marie-Christine Dazza in
Current site
Google Scholar
PubMed
Close
,
Luis Valdemar MenesesINSERM U13/IMEA, Hopital Claude Bernard, Servicio de Gatroenterologia, Hospital Central de Maputo, Innogenetics, Paris, France

Search for other papers by Luis Valdemar Meneses in
Current site
Google Scholar
PubMed
Close
,
Pierre-Marie GirardINSERM U13/IMEA, Hopital Claude Bernard, Servicio de Gatroenterologia, Hospital Central de Maputo, Innogenetics, Paris, France

Search for other papers by Pierre-Marie Girard in
Current site
Google Scholar
PubMed
Close
,
Pascal AstagneauINSERM U13/IMEA, Hopital Claude Bernard, Servicio de Gatroenterologia, Hospital Central de Maputo, Innogenetics, Paris, France

Search for other papers by Pascal Astagneau in
Current site
Google Scholar
PubMed
Close
,
Carlos VillaroelINSERM U13/IMEA, Hopital Claude Bernard, Servicio de Gatroenterologia, Hospital Central de Maputo, Innogenetics, Paris, France

Search for other papers by Carlos Villaroel in
Current site
Google Scholar
PubMed
Close
,
Eric DelaporteINSERM U13/IMEA, Hopital Claude Bernard, Servicio de Gatroenterologia, Hospital Central de Maputo, Innogenetics, Paris, France

Search for other papers by Eric Delaporte in
Current site
Google Scholar
PubMed
Close
, and
Bernard LarouzeINSERM U13/IMEA, Hopital Claude Bernard, Servicio de Gatroenterologia, Hospital Central de Maputo, Innogenetics, Paris, France

Search for other papers by Bernard Larouze in
Current site
Google Scholar
PubMed
Close
Restricted access

To study the relationship between hepatocellular carcinoma (HCC) and hepatitis C virus (HCV), sera from 178 patients with HCC and 194 blood donors from Maputo, Mozambique were tested for antibodies to HCV (anti-HCV) using a second generation enzyme-linked immunosorbent assay and a confirmatory test with six synthetic peptides as reagents. The presence of hepatitis B surface antigen (HBsAg) was tested using an enzyme immunoassay. The prevalence of anti-HCV was higher in patients with HCC than in controls, but the difference was not significant after adjustment for age. Therefore, this difference reflected a difference in the age structure between the two groups. The prevalence of HBsAg was higher in patients with HCC than in controls. There was a negative association between anti-HCV and HBsAg in patients with HCC that was not significant after adjustment for age. These serologic results, which contrast with previous reports, show the need for further studies on the relationship between HCC and HCV using second generation serologic tests and molecular biology techniques.

Save